Is there a difference between an angiotensin-converting enzyme inhibitor and an angiotensin-specific receptor blocker for the treatment of hypertension?

Abstract:

The renin-angiotensin system (RAS) and angiotensin II, in
particular, play a central role and have been implicated in the
spectrum of cardiovascular disease (CVD), beginning with
hypertension, diabetes mellitus, atherosclerosis, myocardial
infarction (MI), strokes and heart failure.

BACKGROUND. Hypertension poses a huge financial risk to any funder/medical aid, including the risk-mitigating strategies provided by the managed
care organisations that are required to manage patients with hypertension. ...

This article discusses seven issues in the management of hypertension in diabetic patients, namely the importance of blood pressure control, optimal blood pressure control levels, the importance of blocking the renin-angiotensin ...